3）Rasool MI, Bairam AF, Gohal SA, El Daibani AA, Alherz FA, Abunnaja MS, et al. Effects of the human SULT1A1 polymorphisms on the sulfation of acetaminophen,O-desmethylnaproxen, and tapentadol. Pharmacol Rep 2019; 71(2): 257-65.4）Bairam AF, Rasool MI, Alherz FA, Abunnaja MS, El Daibani AA, Kurogi K, et al. Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3. Arch Biochem Biophys 2018; 648: 44-52.1）Matsumura S, Oshima A, Fujinuma S, Tanaka K, Nagano N, Miyake F, et al. Low-dose intravenous paracetamol for patent ductus arteriosus in indomethacin-resistant or contraindicated preterm infants: three cases reports. AJP Rep 2017; 7(4): e230-e233.2）Oshima A, Matsumura S, Iwatani A, Morita M, Fujinuma S, Motojima Y, et al. Safety and feasibility of intravenous paracetamol for patent ductus arteriosus in indomethacin-/ibuprofen-resistant or -contraindicated preterm infants: a case series. AJP Rep 2020; 10(1): e49-e53.5）Court MH, Freytsis M, Wang X, Peter I, Guillemette C, Hazarika S, et al. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J pharmacol Exp Ther 2013; 345(2): 297-307.6）Allegaert K, Van der Marel CD, Debeer A, Pluim MA, Van Lingen RA, Vanhole C, et al. Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age. Arch Dis Child Fetal Neonatal Ed 2004; 89(1): F25-8.8383文 献
元のページ ../index.html#97